Curvafix intramedullary device patent granted
Summary
USPTO granted patent US12588930B2 to Curvafix, Inc. on March 31, 2026, covering implantable intramedullary devices enabling delivery of liquid materials into bone channels. The patent includes 22 claims and names Eric Whittaker, Steven Dimmer, and Blake Matsuzaki as inventors. CPC classifications include A61B 17/72 and related surgical device categories.
What changed
USPTO issued patent US12588930B2 to Curvafix, Inc. for an intramedullary device system that delivers liquid materials such as bone cement, biologics, and pharmacologic solutions directly into intramedullary channels. The filing date was February 4, 2023, under application number 18164584. The patent includes 22 claims covering the device, delivery systems, and methods of use.
Patent grants establish intellectual property rights and do not impose compliance obligations on other market participants. Competitors developing similar bone cement delivery systems or intramedullary implant products should review the patent claims to assess potential freedom-to-operate concerns. No immediate regulatory action or filing is required based on this grant.
Archived snapshot
Apr 1, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Devices, systems, and methods of use for delivery of materials in combination with intramedullary devices
Grant US12588930B2 Kind: B2 Mar 31, 2026
Assignee
Curvafix, Inc.
Inventors
Eric Whittaker, Steven Dimmer, Blake Matsuzaki
Abstract
Implantable intramedullary devices, and systems and methods related thereto, are provided which enable the delivery of a liquid material into an intramedullary channel. An implantable intramedullary device may include a delivery channel through which liquid material may be delivered through the device into the intramedullary channel. The intramedullary device may be adapted for coupling to a fluid delivery apparatus which delivers the liquid material into the delivery channel of the intramedullary device. Delivery catheters configured for insertion into implantable intramedullary devices are also disclosed. Liquid materials which may be delivered include bone cement, biologics, pharmacologic solutions, and other materials useful in conjunction with treatments involving intramedullary implants.
CPC Classifications
A61B 17/72 A61B 17/7233 A61B 17/7208 A61B 17/88 A61B 17/8805 A61B 17/8816 A61B 17/58 A61B 17/86 A61B 17/8685 A61B 17/864 A61B 17/70
Filing Date
2023-02-04
Application No.
18164584
Claims
22
Related changes
Get daily alerts for USPTO Patent Grants - Diagnosis & Surgery (A61B)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Diagnosis & Surgery (A61B) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.